BioSpace News Archive

Clinical Nutrition Market: Top 3 trends bolstering the industry outlook

Expansion of the baby boomer population infected with digestive ailments, encouraging the external supply of food with the help of parenteral or enteral routes will enhance the demand for clinical nutrition products.

January 7, 2021
·
4 min read
Drug Development

University of Maryland School of Medicine Begins Phase 3 Trial of Novavax COVID-19 Vaccine Candidate

Monica McArthur, MD, PhDResearchers at the University of Maryland School of Medicine (UMSOM) will participate in a Phase 3 clinical trial of an investigational COVID-19 vaccine to protect against SARS-CoV-2, the coronavirus causing COVID-19 that continues to impact millions of people around the world.

January 7, 2021
·
6 min read
Birmingham research paves the way for new anti-fibrotic therapy for glaucoma

Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible blindness.

January 7, 2021
·
4 min read
BioCapital

Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that it has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate.

January 7, 2021
·
5 min read
Gutta-percha Market Detailed Analysis and Forecast by 2030

Gutta percha has emerged as perhaps the most common and certainly irreplaceable endodontic filling or obturating material in dentistry.

January 7, 2021
·
3 min read
Deals

DermTech Announces Pricing of Public Offering of Common Stock - Jan 07, 2021

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced the pricing of its previously announced underwritten public offering of 4,237,288 shares of its common stock at a price to the public of $29.50 per share.

January 7, 2021
·
5 min read
Deals

Sensorion Announces Initiation of Coverage by Investment Banks Jefferies and Kempen With a “Buy” Recommendation

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces that the investment banks Jefferies and Kempen have initiated analyst coverage of Sensorion.

January 7, 2021
·
3 min read
Policy

OncoZenge announces issue of European Patent related to BupiZenge®

OncoZenge AB, Moberg Pharma’s subsidiary, announced that the European Patent Office has granted patent 3 284 459 which protects BupiZenge®, currently in development for treatment of pain due to oral mucositis.

January 7, 2021
·
2 min read
Business

Leading Microbiologist, Dr. Robert E.W. Hancock Appointed as Executive Chairman of Core One Labs

Core One Labs Inc. is pleased to announce the appointment of Dr. Robert E.W. Hancock as Executive Chairman of the Company, effective January 6, 2021.

January 7, 2021
·
5 min read
Deals

MilliporeSigma Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

Adds to MilliporeSigma’s lipid manufacturing expertise, providing an integrated offering across mRNA value chain

January 7, 2021
·
5 min read